LEADER 03833nam  22005055  450 
001 9910320753103321
005 20200701010820.0
010   $a3-319-94854-7
024 7 $a10.1007/978-3-319-94854-6
035   $a(CKB)4100000007881195
035   $a(MiAaPQ)EBC5771155
035   $a(DE-He213)978-3-319-94854-6
035   $a(PPN)235670588
035   $a(EXLCZ)994100000007881195
100   $a20190410d2018      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aEbola Virus Disease $eA Manual for EVD Management /$fedited by Marta Lado
205   $a1st ed. 2018.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2018.
215   $a1 online resource (193 pages)
311   $a3-319-94853-9 
327   $aEVD INTRODUCTION -- Virology and VHF diseases: Ebola, Marbung, Lassa.-History of previous outbreaks -- Sources of the infection, ways of transmission -- CLINICAL FEATURES AND CASE DEFINITION -- Clinical features: incubation period, clinical presentation and post Ebola syndrome -- RESPONSE TO EVD OUTBREAK -- Screening of suspected cases in a referral Hospital: variability of the case definition adapted to the outbreak. Screening forms and Standard precautions -- Isolation Unit: how to set up and construct a holding unit in a hospital and satellite clinics -- Personal protection equipment (PPE) and Infection prevention and control (IPC) measures -- Waste management and cleaning/disinfection -- Safe Medical Burials: practical and cultural implications -- EVD MANAGEMENT -- Symptomatic, supportive treatment- differences between treatment in the field and high resources settings (Europe, US) -- Special populations: pregnancy and pediatrics -- Controversies with invasive therapies: dialysis, ventilation -- New therapies, Experimental drugs (Zmapp, Favipiravir, convalescent serum, etc) and vaccines -- DIAGNOSTICS EVD -- Rapid tests for EVD -- Laboratory: RT-PCR, serology and Ag determination.
330   $aThis current manual gives an overview to management of Ebola Virus Disease outbreaks from a practical point of view. It gives an introduction to the topic, reviews the history and previous outbreaks of Ebola virus disease and gives insight to clinical features of the disease. The major part of the book presents ways of response including screening, isolation and personal protection equipment as well as waste management during disease outbreaks. New therapies and experimental drugs are discussed in further detail. The last part of the volume deals with all aspects of diagnostics and practical laboratory handling of Ebola virus. Dr. Marta Lado is the clinical lead of the King?s Sierra Leone Partnership in country team. She brings together a group of authors aggregating both well-grounded basic knowledge on Ebola virus as well as deep experience with Ebola Virus Disease in the field.
606   $aMedical microbiology
606   $aHealth promotion
606   $aVirology
606   $aMedical Microbiology$3https://scigraph.springernature.com/ontologies/product-market-codes/B16003
606   $aHealth Promotion and Disease Prevention$3https://scigraph.springernature.com/ontologies/product-market-codes/H27010
606   $aVirology$3https://scigraph.springernature.com/ontologies/product-market-codes/B22003
615  0$aMedical microbiology.
615  0$aHealth promotion.
615  0$aVirology.
615 14$aMedical Microbiology.
615 24$aHealth Promotion and Disease Prevention.
615 24$aVirology.
676   $a614.588
702   $aLado$b Marta$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910320753103321
996   $aEbola Virus Disease$92529410
997   $aUNINA